Angiogenesis
Products for Angiogenesis
- Cat.No. Product Name Information
-
GC38873
α2β1 Integrin Ligand Peptide TFA
-
GC62380
αvβ1 integrin-IN-1
-
GC62566
αvβ1 integrin-IN-1 TFA
-
GC45269
(±)10(11)-DiHDPA
(±)10(11)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid.
-
GC41212
(±)10(11)-EpDPA
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers.
-
GC40466
(±)11(12)-EET
(±)11(12)-EET is a fully racemic version of the R/S enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes.
-
GC41648
(±)13(14)-DiHDPA
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases.
-
GC41191
(±)13(14)-EpDPA
Cytochrome P450 metabolism of polyunsaturated fatty acids produces numerous bioactive epoxide regioisomers.
-
GC41653
(±)16(17)-DiHDPA
(±)16(17)-DiHDPA is produced from cytochrome P450 epoxygenase action on docosahexaenoic acid.
-
GC41655
(±)19(20)-EDP Ethanolamide
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively).
-
GC41203
(±)7(8)-EpDPA
Docosahexaenoic acid is the most abundant ω-3 fatty acid in neural tissues, especially in the brain and retina.
-
GC34069
(±)-Zanubrutinib ((±)-BGB-3111)
-
GC63797
(S)-Sunvozertinib
-
GC16195
2,4-DPD
cell permeable, competitive inhibitor of HIF-PH
-
GC17368
2-Furoyl-LIGRLO-amide
Protease-activated receptor agonist
-
GC38731
2-Furoyl-LIGRLO-amide TFA
-
GC15084
2-Methoxyestradiol (2-MeOE2)
Apoptotic, antiproliferative and antiangiogenic agent
-
GC14282
3-acetyl-11-keto-β-Boswellic Acid
A 5-lipoxygenase inhibitor
-
GC49562
4-methoxy Estrone
An active metabolite of estrone
-
GC15557
A 205804
E-selectin/ICAM-1 expression inhibitor
-
GC15192
A 286982
A LFA-1/ICAM-1 interaction inhibitor
-
GC14831
AC 264613
PAR2 agonist,potent and selective
-
GC15290
AC 55541
PAR2 agonist,potent and selective
-
GC60551
Acalabrutinib D4
-
GC15453
ACP-196
irreversible BTK inhibitor
-
GC32083
Acriflavine
-
GC12487
Adaptaquin
HIF-prolyl hydroxylase-2 (PHD2) inhibitor
-
GC33416
AFP464
-
GC31679
ARQ 531
-
GC63896
AS-1763
-
GC34133
ATN-161
-
GC33837
ATN-161 trifluoroacetate salt (ATN-161 TFA salt)
-
GC63658
Atopaxar
-
GC13562
AVL-292
Btk inhibitor
-
GC42887
Axitinib Sulfoxide
Axitinib sulfoxide is a major inactive metabolite of the tyrosine kinase inhibitor axitinib.
-
GC15817
AY-NH2
Selective PAR4 agonist
-
GC18152
AZ-3451
A potent, and selective PAR2 antagonist with Kd of 13.5 nM.
-
GC12698
BAY 87-2243
A HIF-1 inhibitor,potent and selective
-
GC63846
BIIB091
-
GC17560
BIO 1211
An α4β1 inhibitor,selective and high affinity
-
GC14208
BIO 5192
α4β1 inhibitor
-
GC60077
BIO5192 hydrate
-
GC50078
BIRT 377
Potent negative allosteric modulator of LFA-1
-
GC18717
BMS 986120
A selective PAR4 antagonist
-
GC62872
BMS-587101
-
GC38893
BMS-688521
-
GC31760
BMS-935177
-
GC31713
BMS-986142
-
GC32844
BMS-986195
-
GC11063
BMX-IN-1
BMX (also termed ETK) kinase inhibitor
-
GC50325
BOP
Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs
-
GC19333
BTK IN-1
BTK IN-1 is a potent BTK inhibitor, with an IC50 of <100 nM.
-
GC35561
Btk inhibitor 1
-
GC35562
Btk inhibitor 1 hydrochloride
-
GC10924
Btk inhibitor 1 R enantiomer
Btk kinase inhibitor
-
GC35563
Btk inhibitor 1 R enantiomer hydrochloride
-
GC62498
BTK inhibitor 17
-
GC64360
BTK inhibitor 18
-
GC32007
Btk inhibitor 2
-
GC50075
BTT 3033
Selective inhibitor of integrin α2β1
-
GC38128
c(phg-isoD-G-R-(NMe)k) TFA
-
GC32042
Carotegrast
-
GC62143
Carotegrast methyl
-
GC43198
CAY10717
CAY10717 is a multi-targeted kinase inhibitor that exhibits greater than 40% inhibition of 34 of 104 kinases in an enzymatic assay at a concentration of 100 nM.
-
GC33064
CG-806 (Luxeptinib)
An inhibitor of FLT3/BTK and other kinases
-
GC13365
CGI-1746
Btk inhibitor
-
GN10518
Chitosamine hydrochloride
Extracted from natural chitin;Store the product in sealed, cool and dry condition
-
GN10308
Chlorogenic acid
A phenolic product with antioxidant activity
-
GC13559
Cilengitide
Integrin inhibitor for αvβ3 and αvβ5
-
GC61520
Cilengitide TFA
-
GC45880
Cimetidine-d3
-
GC13439
CNX-774
BTK inhibitor, orally active, irreversible and selective
-
GC17631
Combretastatin A4
tubulin polymerization inhibitor
-
GN10535
Cucurbitacin B
A natural compound with anti-cancer activity
-
GC13050
CWHM-12
An inhibitor of αV integrins
-
GC17610
Cyclo (-RGDfK)
An inhibitor of αvβ3 integrin
-
GA21306
Cyclo(-Arg-Gly-Asp-D-Tyr-Lys)
c(RGDyK) has been radioiodinated or modified with chelators for use as radiopharmaceutical.
-
GC60117
Cyclo(-RGDfK) TFA
-
GC34141
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA
-
GC30111
Cyclo(RADfK)
-
GC13923
Cyclo(RGDyK)
An αVβ3 integrin inhibitor
-
GC49716
Cyclo(RGDyK) (trifluoroacetate salt)
A cyclic peptide ligand of αVβ3 integrin
-
GC16647
Daprodustat(GSK1278863)
HIF-prolyl hydroxylase inhibitor
-
GC31230
Dencichin (Dencichine)
-
GC38767
Deoxyshikonin
A natural products with anti-tumor activity
-
GC32449
Desidustat
-
GC16973
DMOG
A competitive HIF-PH inhibitor
-
GC16280
DMXAA (Vadimezan)
A selective inhibitor of DT-diaphorase
-
GC45767
Dovitinib-d8
-
GC19128
E7820
E7820 is an angiogenesis inhibitor by suppressing integrin a2, a cell adhesion molecule expressed on endothelial cells.
-
GC18236
Echinomycin
An inhibitor of HIF1mediated gene transcription
-
GC62182
Echistatin TFA
-
GC17236
Echistatin, α1 isoform
Potent irreversible αVβ3 integrin antagonist
-
GC33043
EL-102
-
GC33634
Enarodustat (JTZ-951)
-
GC60807
ENMD-1068 hydrochloride
-
GC33170
ENMD-119 (ENMD 1198)
-
GC12447
Eptifibatide
Glycoprotein (GP) IIb/IIIa inhibitor
-
GC13139
FG-4592 (ASP1517)
A HIF prolyl-hydroxylase inhibitor
-
GC16638
FG2216
HIF-prolyl hydroxylase inhibitor